COPD Trial, Recruiting NCT03877653 Sponsor: Curonix LLC Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT03877653
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years of age
  • People who have had ongoing, function-limiting knee pain from osteoarthritis for at least three months, with a pain score above 6 out of 10 on a specific pain scale, whether or not they have had previous knee surgeries
  • People who have been diagnosed with a moderate level of knee osteoarthritis (called Kellgren-Lawrence Grade II or III), confirmed by an X-ray taken within the last year
  • People whose doctor has assessed them as a suitable candidate for the procedure, including those who have already had a total knee replacement
  • People who are able to understand the study and are willing to give written consent to take part
  • People who are able to follow the study procedures and attend all required follow-up appointments at the trial centre
  • People who have tried at least two less invasive treatments without lasting success, such as physical therapy, steroid injections into the joint, or anti-inflammatory medications taken by mouth
  • People who have not had certain knee procedures within specific timeframes before signing the consent form: no steroid injection within the past 2 weeks, and no radiofrequency treatment, cryoablation, or hyaluronic acid injection within the past 4 weeks
  • People who experienced good but only short-term pain relief (more than 75% relief for at least 2 hours) from a local anaesthetic nerve block injection near the knee
  • People who have been assessed by a clinical psychologist and considered psychologically and socially appropriate for an implanted device therapy

Who may not be able to join:

  • People with significant pain in the opposite knee that limits their activity, scoring above 6 on a specific pain scale
  • People whose hip or foot pain is worse than their knee pain
  • People with nerve-related or circulation-related leg pain that causes difficulty walking (confirm with trial site)
  • People diagnosed with a severe level of knee osteoarthritis (Kellgren-Lawrence Grade IV), confirmed by an X-ray taken within the last year
  • People with major depression or other psychiatric conditions that are not well managed
  • People with serious uncontrolled medical conditions, including blood clotting disorders, kidney problems, chronic liver disease, worsening nerve conditions, active infection, unstable chest pain, or severe lung disease
  • People with long-term serious conditions that could make it difficult to accurately measure pain and physical function outcomes, such as rheumatoid arthritis, severe spinal narrowing, or heart disease that limits activity
  • People who are pregnant, planning to become pregnant, or currently breastfeeding
  • People with a Body Mass Index (BMI) over 40
  • People with multiple overlapping pain conditions affecting the knee, foot, or ankle, or nerve-related pain that would make it difficult to clearly assess results
  • People whose anatomy has been assessed by a doctor as unsuitable for the procedure
  • People with lymphoedema, leg ulcers, or other conditions that could affect healing at the procedure site
  • People who have had a previous bad reaction to local anaesthetic medications
  • People who are workers' compensation claimants
  • People who are incarcerated or wearing an ankle monitoring device
  • People with a known allergy to the materials used in the device
  • People with known or suspected substance abuse within the last two years
  • People who have a pacemaker or an implanted heart defibrillator
  • People currently participating in another clinical study that could affect the results of this trial
  • People for whom the investigator has identified legal or medical concerns that could affect their participation or the reliability of results
  • People who already have another active implanted medical device in the same area of the body

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0032 492 69 22 23

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Curonix LLC
Registry
ClinicalTrials.gov
Start date
1 September 2021
Est. completion
1 October 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Responder rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov